3 Pulmonary Embolism Clinical Trials in Hackensack, NJ (2026)

Q: How do I join a clinical trial in Hackensack?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hackensack research site will contact you.

Recruiting Pulmonary Embolism Studies in Hackensack

NCT03813407Recruiting

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

Sodium zirconium cyclosilicate has been shown to be effective and safe in adults for the treatment of hyperkalaemia, and therefore it is expected to be beneficial in children. This study will evaluate...

Hackensack, NJPHASE3140 participantsAstraZeneca

View Study Details

NCT07223944Recruiting

A Gaucher Disease Gene Therapy Trial With FLT201

This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate re...

Hackensack, NJPHASE345 participantsSpur Therapeutics

View Study Details

NCT07226453Recruiting

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

This is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma....

Hackensack, NJPHASE230 participantsUniversity of California, San Francisco

View Study Details

About Pulmonary Embolism Clinical Trials in Hackensack

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 3 pulmonary embolism clinical trials recruiting participants in Hackensack, NJ. These studies are seeking a combined 215 participants. Research is being sponsored by AstraZeneca, Spur Therapeutics, University of California, San Francisco. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Hackensack — FAQ

Are there pulmonary embolism clinical trials in Hackensack?

Yes, there are 3 pulmonary embolism clinical trials currently recruiting in Hackensack, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hackensack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hackensack research site will contact you about next steps.

Are clinical trials in Hackensack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hackensack studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 3 active trials in Hackensack are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated October 12, 2026 from ClinicalTrials.gov